Inhibitor Therapeutics, Inc. Interest Payable, Current
Inhibitor Therapeutics, Inc. (INTI) had Interest Payable, Current of $34.84 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2023-03-31
- 2022-09-30: Interest Payable, Current $34.84K.
- 2022-06-30: Interest Payable, Current $27.14K.
- 2022-03-31: Interest Payable, Current $20.38K.
- 2021-12-31: Interest Payable, Current $14.96K.
| Period end | Interest Payable, Current |
|---|---|
| 2022-09-30 | $34.84K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $27.14K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $20.38K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $14.96K 10-K · filed 2023-03-31 |
| 2021-09-30 | $10.16K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $5.36K 10-Q · filed 2021-08-13 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2014-09-30 | $847.00 10-Q · filed 2014-10-10 |
| 2014-06-30 | $2.48K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $2.21K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.92K 10-K · filed 2015-02-13 |